There was a rumour that Johnson and Johnson were running their ruler over it.
The bigger world players in Blood Plasma is only Baxter in the US and the feeling is that the anti trust people would not allow it.
That means it would need to be another pharmeautical company like Merck - anything is a possability, but the to price would need to be a big premium over the current sp; esp when holders have seen phenomonal sp growth over the years. Why give that up? I would be hard to budge.
HT1
csl falls below spp price, page-12
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$299.95 |
Change
-1.710(0.57%) |
Mkt cap ! $145.4B | |||
| Open | High | Low | Value | Volume |
| $303.31 | $303.47 | $299.56 | $97.70M | 328.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13 | $299.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $299.96 | 19 | 3 |
View Market Depth
| Last trade - 15.56pm 13/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |